Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Sep;58(3):362–367. doi: 10.1038/bjc.1988.220

Double antibody radioimmunoassay for monitoring metastatic breast cancer.

R L Schecter 1, P P Major 1, P E Kovac 1, M Ishida 1, E C Kovalik 1, A S Dion 1, A Langleben 1, G Boileau 1, G Boos 1, L Panasci 1, et al.
PMCID: PMC2246609  PMID: 3179189

Abstract

We previously reported the production of a panel of murine monoclonal antibodies which recognize glycoproteins abnormally expressed in human breast tumours. Using two of these antibodies, a double antibody radioimmunoassay was designed to quantify levels of these breast tumour marker glycoproteins in serum. Marker levels greater than 28 units were considered abnormal. Using this criterion, 63% and 75% of patients with breast cancer stages I and II, respectively, and 88% of those with metastatic disease were found to have elevated marker levels. Thirteen percent of patients with non-malignant breast disease also had elevated marker levels. Elevated marker levels were also detected in patients with non breast neoplasms. One hundred and eleven women with metastatic disease were followed. Eighty-two percent of those with progressive disease and 73% of those where disease regressed had 20% changes in marker levels. These changes in marker levels preceded by up to 6 months changes in disease state. From these results we conclude that this assay may be useful for monitoring the course of disease in breast cancer patients.

Full text

PDF
362

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  2. Borthwick N. M., Wilson D. W., Bell P. A. Carcinoembryonic antigen (CEA) in patients with breast cancer. Eur J Cancer. 1977 Feb;13(2):171–176. doi: 10.1016/0014-2964(77)90196-7. [DOI] [PubMed] [Google Scholar]
  3. Burchell J., Wang D., Taylor-Papadimitriou J. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer. Int J Cancer. 1984 Dec 15;34(6):763–768. doi: 10.1002/ijc.2910340605. [DOI] [PubMed] [Google Scholar]
  4. Ceriani R. L., Sasaki M., Sussman H., Wara W. M., Blank E. W. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5420–5424. doi: 10.1073/pnas.79.17.5420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chu T. M., Nemoto T. Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst. 1973 Oct;51(4):1119–1122. doi: 10.1093/jnci/51.4.1119. [DOI] [PubMed] [Google Scholar]
  6. De Jong-Bakker M., Hart A. A., Persijn J. P., Cleton F. J. Prognostic significance of CEA in breast cancer: a statistical study. Eur J Cancer Clin Oncol. 1981 Dec;17(12):1307–1313. doi: 10.1016/0014-2964(81)90013-x. [DOI] [PubMed] [Google Scholar]
  7. Del Villano B. C., Brennan S., Brock P., Bucher C., Liu V., McClure M., Rake B., Space S., Westrick B., Schoemaker H. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem. 1983 Mar;29(3):549–552. [PubMed] [Google Scholar]
  8. Haagensen D. E., Jr, Kister S. J., Vandevoorde J. P., Gates J. B., Smart E. K., Hansen H. J., Wells S. A., Jr Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer. 1978 Sep;42(3 Suppl):1512–1519. doi: 10.1002/1097-0142(197809)42:3+<1512::aid-cncr2820420824>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  9. Hilkens J., Kroezen V., Bonfrer J. M., De Jong-Bakker M., Bruning P. F. MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res. 1986 May;46(5):2582–2587. [PubMed] [Google Scholar]
  10. Klug T. L., Bast R. C., Jr, Niloff J. M., Knapp R. C., Zurawski V. R., Jr Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 1984 Mar;44(3):1048–1053. [PubMed] [Google Scholar]
  11. Major P. P., Kovac P. E., Lavallée M. L., Kovalik E. C. Monoclonal antibodies to antigens abnormally expressed in breast cancer. J Histochem Cytochem. 1987 Feb;35(2):139–148. doi: 10.1177/35.2.3540102. [DOI] [PubMed] [Google Scholar]
  12. Major P., Lavallée M., Minassian H., Kovac P., Wang N. S. Ultrastructural localization of a breast tumor-associated antigen. J Histochem Cytochem. 1987 Mar;35(3):375–379. doi: 10.1177/35.3.3546485. [DOI] [PubMed] [Google Scholar]
  13. Papsidero L. D., Nemoto T., Croghan G. A., Chu T. M. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Cancer Res. 1984 Oct;44(10):4653–4657. [PubMed] [Google Scholar]
  14. Rochester D. F. The diaphragm: contractile properties and fatigue. J Clin Invest. 1985 May;75(5):1397–1402. doi: 10.1172/JCI111841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Salinas F. A., Wee K. H., Ceriani R. L. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies. Cancer Res. 1987 Feb 1;47(3):907–913. [PubMed] [Google Scholar]
  16. Sekine H., Hayes D. F., Ohno T., Keefe K. A., Schaetzl E., Bast R. C., Knapp R., Kufe D. W. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. J Clin Oncol. 1985 Oct;3(10):1355–1363. doi: 10.1200/JCO.1985.3.10.1355. [DOI] [PubMed] [Google Scholar]
  17. Swenerton K. D., Legha S. S., Smith T., Hortobagyi G. N., Gehan E. A., Yap H. Y., Gutterman J. U., Blumenschein G. R. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979 May;39(5):1552–1562. [PubMed] [Google Scholar]
  18. Thompson C. H., Jones S. L., Whitehead R. H., McKenzie I. F. A human breast tissue-associated antigen detected by a monoclonal antibody. J Natl Cancer Inst. 1983 Mar;70(3):409–419. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES